The global peripheral vascular stent market is on a rapid growth trajectory, projected to nearly double from USD 4.59 billion in 2025 to USD 9.55 billion by 2035. This significant expansion represents a robust Compound Annual Growth Rate (CAGR) of 7.6% over the forecast period. The surge is primarily fueled by the escalating global incidence of Peripheral Artery Disease (PAD), driven by an aging population, evolving lifestyle factors, and rising rates of chronic conditions such as diabetes and hypertension.
Peripheral vascular stents offer crucial advantages, including minimally invasive placement, improved vessel patency, and reduced restenosis rates, making them increasingly adopted in vascular surgeries, particularly for lower extremity revascularization procedures. Growing awareness of PAD treatment options and the increasing availability of advanced stent technologies are further bolstering market demand.
Click Here for More Information:- https://www.futuremarketinsights.com/reports/peripheral-vascular-stents-market
Competitive Landscape and Innovation:
The peripheral vascular stent market is highly competitive, with leading manufacturers intensely focused on product innovation and technological advancements. Companies are heavily investing in the development of next-generation drug-eluting and bioresorbable stents designed to improve long-term patient outcomes and minimize complications. Advances in stent materials, such as ultra-thin struts and enhanced polymer coatings, are leading to better deliverability and flexibility, enabling clinicians to treat complex and tortuous lesions more effectively.
The market is also witnessing the emergence of bioabsorbable scaffolds, smart stent designs integrated with imaging markers, and AI-driven procedural guidance, all of which are reshaping clinical practices in vascular interventions. As precision medicine gains traction, personalized stent solutions are also coming to the forefront, offering tailored treatments for complex PAD cases and allowing companies to differentiate their offerings.
Key players like Medtronic Plc., Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, and B. Braun Melsungen AG are at the forefront of this innovation. Their growth is stimulated by the increasing volume of cardiovascular surgeries performed using minimally invasive techniques. Manufacturers are also employing market penetrative strategies, including strategic acquisitions and mergers, to gain a larger foothold in emerging markets. For instance, in November 2019, Sahajanand Medical Technologies (SMT) acquired a majority stake in a Brazilian sales and marketing company to establish a strong overseas presence in Latin America.
Recent developments further highlight the market’s dynamic nature:
- In March 2024, Becton, Dickinson, and Company (BD) initiated a PAD treatment study focusing on a new vascular-covered stent.
- Concept Medical Inc. made headlines in January 2025 with its “MagicTouch,” the world’s first Sirolimus-coated balloon, offering new hope for millions suffering from peripheral vascular disease.
- ETH Zurich researchers are developing malleable microstructure production utilizing indirect 4-D printing, a technology with potential applications in stent development.
Market Segmentation Highlights:
- Product Type: While self-expanding stents currently hold a significant 53.1% market share in 2025 due to their flexibility, drug-eluting stents (DES) are experiencing increasing demand. Their ability to reduce restenosis and improve long-term vascular outcomes makes them the preferred choice for complex PAD interventions, especially in aging populations with comorbidities.
- Artery Type: The iliac artery segment accounts for a substantial 48% market share in 2025. However, the femoral-popliteal (fem-pop) artery segment is witnessing strong demand growth, driven by the high incidence of PAD in this susceptible region and recent innovations in stent flexibility and drug delivery.
- End User: Ambulatory Surgical Centers (ASCs)/Outpatients are projected to be the fastest-growing segment, with a CAGR of 7.9% from 2025 to 2035. This trend is fueled by the healthcare industry’s shift towards cost-effective, patient-friendly outpatient vascular interventions. Hospitals, however, remain crucial for complex cases and emergency situations.
Regional Growth Drivers:
- China is predicted to lead regional expansion with an impressive 10.30% CAGR over the forecast period, driven by a growing patient base for high-risk cardiovascular diseases and the availability of affordable stents.
- The United Kingdom peripheral vascular stent market is projected to expand at a 6.40% CAGR, supported by increasing research studies aimed at widening PAD treatment options, such as BD’s “AGILITY” IDE study.
- India is expected to see a 7.10% CAGR, propelled by an expanding patient pool, increasing elderly population, and the rising popularity of cost-effective surgeries and advanced equipment.
- GCC Countries are set to increase at a 7.60% CAGR, with industry participants focusing on educational campaigns for high-risk populations and investing in new technologies to enhance their portfolios.
- The United States market is estimated to grow at a 5.90% CAGR, driven by the broad availability of newly approved drug-eluting stents, an expanding geriatric population, and the increasing utilization of peripheral stent implants.
The peripheral vascular stent market is poised for significant growth, driven by a combination of increasing disease prevalence, continuous technological innovation, and evolving healthcare delivery models focused on patient-centric outcomes.
Get Sample Report: – https://www.futuremarketinsights.com/reports/sample/rep-gb-2091
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
